Get the app
USHealthcare

Hinge Health, Inc. (HNGE)

US · Healthcare · Health Information Services

$94.72+1.06%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$212.8M
Revenue YoY
+53.0%
Net profit
$43.7M
EPS
$0.66
EPS estimate
$0.28
Net margin
20.5%

EPS came in at 0.66 against a street estimate of 0.28 — a beat of 135.7%.

Key statistics

Market cap
$7.15B
P/E
10.8
Forward P/E
30.6
P/B
20.76
Book value
$4.29
EPS (TTM)
$8.22
52-week high
$95.57
52-week low
$30.08
50-day MA
$86.02
200-day MA
$57.71

Analyst view

with an average price target of $107.73.

From the latest earnings call · 2026-08-04

CONFIDENT Hinge Health delivered Q2 revenue of $213M (+53% YoY), well above guidance. Operating margin expanded to 29%. Company acquiring Cylinder Health for $105M to enter GI market. Raising full-year guidance on sustained yield improvements. Q2 2026 Call did not discuss geographic breakdown. Cylinder noted no material geographic concentration; digital health operates across all 50 states. Analysts pressed on competitive positioning (win rates), Cylinder integration risks & margin impact, and yield sustainability across SMB/enterprise. Management emphasized product quality, clinical evidence, and reusable platform as differentiators; downplayed rival claims and framed Cylinder as accretive long-term. 2026-08-04…

Full summary in the app.

Shareholding

Insiders
4.98%
Institutions
95.21%

Largest institutional holders

FundStake
Deer Management Co. LLC3.26%
11.2 Capital Management, LLC3.05%
RTW INVESTMENTS, LLC2.39%
Two Sigma Investments LLC2.24%
Fuller & Thaler Asset Management Inc2.05%
BRAIDWELL LP1.80%
Vanguard Portfolio Management, LLC1.75%
Vanguard Capital Management, LLC1.53%

Recent filings & reports

DocumentDate
Material agreement · Q3 2026
HINGE HEALTH, INC. – FORM 8-K SUMMARY Report Date: August 18, 2026 --- HEADLINE NUMBERS • New office lease commitment: $86.0 million in aggregate b
2026-08-21
Quarterly report · Q2 2026
HINGE HEALTH, INC. – Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Revenue (Q2 2026): $212.8 million, up 53% from $139.1 million in Q2 2025 • Revenue (H1
2026-08-06
Results announced · Q3 2026
HINGE HEALTH Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Revenue increased 53% year-over-year to $212.8 million in Q2 2026 (vs. $139.1 million in Q2
2026-08-04
Reg FD disclosure · Q2 2026
HINGE HEALTH, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Company raised guidance for Q2 2026 and full year 2026 • Specific financial figures for rai
2026-06-09
Shareholder vote results · Q2 2026
HINGE HEALTH, INC. – FORM 8-K SUMMARY HEADLINE NUMBERS • Annual Meeting of Stockholders held June 3, 2026 • Two proposals voted on by shareholders •
2026-06-04
Quarterly report · Q1 2026
HINGE HEALTH, INC. – Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Revenue Q1 2026: $182.3 million (up 47% from $123.8 million in Q1 2025) • Net Income Q1
2026-05-07
Proxy statement · Q2 2026
HINGE HEALTH, INC. — PROXY STATEMENT SUMMARY CEO COMPENSATION • CEO Daniel Perez's total compensation figures are not disclosed in the provided prox
2026-04-17
Annual report FY2025
HINGE HEALTH, INC. – FORM 10-K SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Market capitalization as of June 30, 2025: $1.5 billion (non-affiliat
2026-03-03

Readable in the app.

Deals & corporate news

AnnouncementDate
Board approves $300 million increase to share repurchase program
Hinge Health announced Q2 2026 financial results on August 4, 2026, along with two significant corporate actions. First, the Board increased the company's share repurchase program by $300 mi
2026-08-04
Raises Q2 2026 and full year 2026 guidance at first Investor Day
Hinge Health, a digital health company, announced two positive developments on June 9, 2026: (1) it is holding its first-ever Investor Day at an event called Movement, and (2) it is raising
2026-06-09
Board authorizes $250 million share repurchase program
Hinge Health announced a $250 million share repurchase program authorized by its board on November 10, 2025. The company will buy back its own stock in the open market or through private tra
2025-11-12
Q4 and FY2025 revenue and operating income guidance raised
Hinge Health, an AI-powered healthcare platform treating musculoskeletal conditions, reported strong Q3 2025 results. Revenue grew 53% year-over-year to $154.2 million, exceeding $100.6 mill
2025-11-04

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Hinge Health, Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Data updated 2026-09-18.